English

Chembio Diagnostics, Inc.

EDGAR

CEMI Annual report (10-K) · filed 2023-03-29

142 filing records in this dataset, filed from 2000-07-14 to 2023-03-29. Reported financial figures are available; chart coverage varies by period.

Inspect reported changes Compare with another company Historical disclosures Search filings Segments

Watchlist

Latest quarter

Revenue

11.2 million U002

2022 Q3 · U002

Exact inputs and evidence

Revenue: 11200148 U002 Source

Operating margin

-53.49%

2022 Q3 · %

Exact inputs and evidence

Operating Income: -5991255 U002 Source
Revenue: 11200148 U002 Source

Operating cash flow

-5.06 million U002

2022 Q3 · U002

Exact inputs and evidence

Operating Cash Flow: -9861916 U002 Source
Operating Cash Flow: -4802145 U002 Source

Cash and cash equivalents: 18.2 million U001 2022-12-31 Source
Exact value

18178985 U001
Long-term debt including current maturities: Not available
Shares outstanding: 36.8 million U002 2022-12-31 Source
Exact value

36765785 U002

Reported share-count change

22.13% · 6.66 million U002

Year-over-year change in reported shares. Splits, issuance and buybacks can affect this figure; it does not isolate employee compensation or economic dilution.

Exact inputs and evidence

30104986 U002 · 2021-12-31· Source
36765785 U002 · 2022-12-31· Source

Includes later revisions to earlier periods. Annual charts exclude incomplete years.

Latest filing recorded: 2023-03-29.

Financial data available through: 2022-12-31.

Coverage by financial measure

Revenue: 11 of 11 periods available· newest 2022-12-31
Operating income: 11 of 11 periods available· newest 2022-12-31
Net income: 11 of 11 periods available· newest 2022-12-31
Operating cash flow: 11 of 11 periods available· newest 2022-12-31
Capital expenditure: 10 of 11 periods available· newest 2021-12-31
Total assets: 11 of 11 periods available· newest 2022-12-31
Total liabilities: 11 of 11 periods available· newest 2022-12-31
Current assets: 11 of 11 periods available· newest 2022-12-31
Current liabilities: 11 of 11 periods available· newest 2022-12-31
Cash and cash equivalents: 11 of 11 periods available· newest 2022-12-31
long term debt: No compatible figures in this window
Shares outstanding: 11 of 11 periods available· newest 2022-12-31

Coverage describes values retained in this snapshot. Missing values are not zero; loading limits are reported separately.

What changed year over year

Latest complete year compared with the corresponding period one year earlier. These are measured changes; they do not establish their business causes.

Revenue
+3.6%

Prior period

U001 47.82 million

2021-01-01 – 2021-12-31
Current period

U001 49.52 million

2022-01-01 – 2022-12-31

Exact inputs and evidence

49521923 − 47818452 = 1703471 U001

47818452 U001 · 2021-01-01 – 2021-12-31
Inspect prior input Prior source
49521923 U001 · 2022-01-01 – 2022-12-31
Inspect current input Current source

Share or cite

Citation for Year-over-year change in Revenue · Chembio Diagnostics, Inc. · 2022-12-31 Chembio Diagnostics, Inc. (edgar:1092662) Year-over-year change in Revenue: 1703471 U001 Concept: fundies:Revenue Period: 2022-01-01 to 2022-12-31 Values: Latest reported Published: 2026-11-02T09:19:19Z Snapshot: 3e30444a4216581077c44f423ce8be06ef2be4055b160acf7d3e4d2760732832 Dimensions: Consolidated View: https://fundies.io/companies/edgar/1092662?view=overview&cadence=annual&surface=latest#period-changes-title Computed: Current period minus corresponding prior-year period Input fundies:Revenue: 49521923 U001 (2022-01-01 to 2022-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1092662/000114036123014526/brhc10050381_10k.htm#1948512 Filing: 000114036123014526 Input fundies:Revenue: 47818452 U001 (2021-01-01 to 2021-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1092662/000114036123014526/brhc10050381_10k.htm#1978570 Filing: 000114036123014526
The citation records this snapshot. The page link may show a newer release later.
Net income
+U001 10.61 million

Prior period

−U001 33.9 million

2021-01-01 – 2021-12-31
Current period

−U001 23.29 million

2022-01-01 – 2022-12-31

Exact inputs and evidence

-23290657 − -33903529 = 10612872 U001

-33903529 U001 · 2021-01-01 – 2021-12-31
Inspect prior input Prior source
-23290657 U001 · 2022-01-01 – 2022-12-31
Inspect current input Current source

Share or cite

Citation for Year-over-year change in Net income · Chembio Diagnostics, Inc. · 2022-12-31 Chembio Diagnostics, Inc. (edgar:1092662) Year-over-year change in Net income: 10612872 U001 Concept: fundies:NetIncome Period: 2022-01-01 to 2022-12-31 Values: Latest reported Published: 2026-11-02T09:19:19Z Snapshot: 3e30444a4216581077c44f423ce8be06ef2be4055b160acf7d3e4d2760732832 Dimensions: Consolidated View: https://fundies.io/companies/edgar/1092662?view=overview&cadence=annual&surface=latest#period-changes-title Computed: Current period minus corresponding prior-year period Input fundies:NetIncome: -23290657 U001 (2022-01-01 to 2022-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1092662/000114036123014526/brhc10050381_10k.htm#1660723 Filing: 000114036123014526 Input fundies:NetIncome: -33903529 U001 (2021-01-01 to 2021-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1092662/000114036123014526/brhc10050381_10k.htm#1661842 Filing: 000114036123014526
The citation records this snapshot. The page link may show a newer release later.
Operating cash flow
+U001 18.19 million

Prior period

−U001 30.89 million

2021-01-01 – 2021-12-31
Current period

−U001 12.69 million

2022-01-01 – 2022-12-31

Exact inputs and evidence

-12693953 − -30885716 = 18191763 U001

-30885716 U001 · 2021-01-01 – 2021-12-31
Inspect prior input Prior source
-12693953 U001 · 2022-01-01 – 2022-12-31
Inspect current input Current source

Share or cite

Citation for Year-over-year change in Operating cash flow · Chembio Diagnostics, Inc. · 2022-12-31 Chembio Diagnostics, Inc. (edgar:1092662) Year-over-year change in Operating cash flow: 18191763 U001 Concept: fundies:OperatingCashFlow Period: 2022-01-01 to 2022-12-31 Values: Latest reported Published: 2026-11-02T09:19:19Z Snapshot: 3e30444a4216581077c44f423ce8be06ef2be4055b160acf7d3e4d2760732832 Dimensions: Consolidated View: https://fundies.io/companies/edgar/1092662?view=overview&cadence=annual&surface=latest#period-changes-title Computed: Current period minus corresponding prior-year period Input fundies:OperatingCashFlow: -12693953 U001 (2022-01-01 to 2022-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1092662/000114036123014526/brhc10050381_10k.htm#1695257 Filing: 000114036123014526 Input fundies:OperatingCashFlow: -30885716 U001 (2021-01-01 to 2021-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1092662/000114036123014526/brhc10050381_10k.htm#1696375 Filing: 000114036123014526
The citation records this snapshot. The page link may show a newer release later.

Comparable inputs unavailable for: Capital expenditure.

Where revenue goes

How a period’s revenue divides into costs and what remains as profit. Items marked Derived are calculated by subtraction from reported figures.

2022 2022-01-01 – 2022-12-31

Revenue U001 49.52 million 100% of revenue
Cost of revenue U001 38.58 million 78% of revenue
Operating expenses U001 31.35 million 63% of revenue
Other operating costs Derived U001 3.24 million 6.5% of revenue
Operating income −U001 23.64 million −48% of revenue
Tax, interest and other Derived −U001 347,390 −0.7% of revenue
Net income −U001 23.29 million −47% of revenue

Cash

Operating cash flow −U001 12.69 million −26% of revenue
Capital expenditure Unavailable An input is unavailable.
Free cash flow Derived Unavailable An input is unavailable.

Share of revenue by period

Net income
Tax, interest and other
Operating costs

2013 97%
2014 Operating loss: operating costs were 106% of revenue.
2015 Operating loss: operating costs were 115% of revenue.
2016 Operating loss: operating costs were 142% of revenue.
2017 Operating loss: operating costs were 127% of revenue.
2018 Operating loss: operating costs were 123% of revenue.
2019 Operating loss: operating costs were 139% of revenue.
2020 Operating loss: operating costs were 171% of revenue.
2021 Operating loss: operating costs were 165% of revenue.
2022 Operating loss: operating costs were 148% of revenue.

Values and sources

Revenue breakdown by annual reporting period
Period	Revenue	Operating costs	Operating income	Tax, interest and other	Net income	Free cash flow	Source
2013 2013-01-01 – 2013-12-31	29549609	28544782 Derived	1004827	474009 Derived	530818	1392005 Derived	Source 2013-01-01 – 2013-12-31: 29549609 U001 Inspect Revenue Open source 2013-01-01 – 2013-12-31: 1004827 U001 Inspect Operating Income Open source 2013-01-01 – 2013-12-31: 530818 U001 Inspect Net Income Open source 2013-01-01 – 2013-12-31: 2277614 U001 Inspect Operating Cash Flow Open source 2013-01-01 – 2013-12-31: 885609 U001 Inspect Capital Expenditure Open source
2014 2014-01-01 – 2014-12-31	27645284	29195537 Derived	-1550253	-413050 Derived	-1137203	-5272900 Derived	Source 2014-01-01 – 2014-12-31: 27645284 U001 Inspect Revenue Open source 2014-01-01 – 2014-12-31: -1550253 U001 Inspect Operating Income Open source 2014-01-01 – 2014-12-31: -1137203 U001 Inspect Net Income Open source 2014-01-01 – 2014-12-31: -3820299 U001 Inspect Operating Cash Flow Open source 2014-01-01 – 2014-12-31: 1452601 U001 Inspect Capital Expenditure Open source
2015 2015-01-01 – 2015-12-31	24255485	27809532 Derived	-3554047	-1157005 Derived	-2397042	1312393 Derived	Source 2015-01-01 – 2015-12-31: 24255485 U001 Inspect Revenue Open source 2015-01-01 – 2015-12-31: -3554047 U001 Inspect Operating Income Open source 2015-01-01 – 2015-12-31: -2397042 U001 Inspect Net Income Open source 2015-01-01 – 2015-12-31: 1792978 U001 Inspect Operating Cash Flow Open source 2015-01-01 – 2015-12-31: 480585 U001 Inspect Capital Expenditure Open source
2016 2016-01-01 – 2016-12-31	17868841	25440618 Derived	-7571777	5775270 Derived	-13347047	-6823440 Derived	Source 2016-01-01 – 2016-12-31: 17868841 U001 Inspect Revenue Open source 2016-01-01 – 2016-12-31: -7571777 U001 Inspect Operating Income Open source 2016-01-01 – 2016-12-31: -13347047 U001 Inspect Net Income Open source 2016-01-01 – 2016-12-31: -6704734 U001 Inspect Operating Cash Flow Open source 2016-01-01 – 2016-12-31: 118706 U001 Inspect Capital Expenditure Open source
2017 2017-01-01 – 2017-12-31	24015427	30497977 Derived	-6482550	-110790 Derived	-6371760	-6061469 Derived	Source 2017-01-01 – 2017-12-31: 24015427 U001 Inspect Revenue Open source 2017-01-01 – 2017-12-31: -6482550 U001 Inspect Operating Income Open source 2017-01-01 – 2017-12-31: -6371760 U001 Inspect Net Income Open source 2017-01-01 – 2017-12-31: -5034515 U001 Inspect Operating Cash Flow Open source 2017-01-01 – 2017-12-31: 1026954 U001 Inspect Capital Expenditure Open source
2018 2018-01-01 – 2018-12-31	34581440	42564108 Derived	-7982668	-117019 Derived	-7865649	-13248633 Derived	Source 2018-01-01 – 2018-12-31: 34581440 U001 Inspect Revenue Open source 2018-01-01 – 2018-12-31: -7982668 U001 Inspect Operating Income Open source 2018-01-01 – 2018-12-31: -7865649 U001 Inspect Net Income Open source 2018-01-01 – 2018-12-31: -11781441 U001 Inspect Operating Cash Flow Open source 2018-01-01 – 2018-12-31: 1467192 U001 Inspect Capital Expenditure Open source
2019 2019-01-01 – 2019-12-31	34464032	47792622 Derived	-13328590	346539 Derived	-13675129	-12558046 Derived	Source 2019-01-01 – 2019-12-31: 34464032 U001 Inspect Revenue Open source 2019-01-01 – 2019-12-31: -13328590 U001 Inspect Operating Income Open source 2019-01-01 – 2019-12-31: -13675129 U001 Inspect Net Income Open source 2019-01-01 – 2019-12-31: -9055506 U001 Inspect Operating Cash Flow Open source 2019-01-01 – 2019-12-31: 3502540 U001 Inspect Capital Expenditure Open source
2020 2020-01-01 – 2020-12-31	32470197	55606489 Derived	-23136292	2385036 Derived	-25521328	-22848607 Derived	Source 2020-01-01 – 2020-12-31: 32470197 U001 Inspect Revenue Open source 2020-01-01 – 2020-12-31: -23136292 U001 Inspect Operating Income Open source 2020-01-01 – 2020-12-31: -25521328 U001 Inspect Net Income Open source 2020-01-01 – 2020-12-31: -18887238 U001 Inspect Operating Cash Flow Open source 2020-01-01 – 2020-12-31: 3961369 U001 Inspect Capital Expenditure Open source
2021 2021-01-01 – 2021-12-31	47818452	78871616 Derived	-31053164	2850365 Derived	-33903529	-32710001 Derived	Source 2021-01-01 – 2021-12-31: 47818452 U001 Inspect Revenue Open source 2021-01-01 – 2021-12-31: -31053164 U001 Inspect Operating Income Open source 2021-01-01 – 2021-12-31: -33903529 U001 Inspect Net Income Open source 2021-01-01 – 2021-12-31: -30885716 U001 Inspect Operating Cash Flow Open source 2021-01-01 – 2021-12-31: 1824285 U001 Inspect Capital Expenditure Open source
2022 2022-01-01 – 2022-12-31	49521923	73159970 Derived	-23638047	-347390 Derived	-23290657	Unavailable	Source 2022-01-01 – 2022-12-31: 49521923 U001 Inspect Revenue Open source 2022-01-01 – 2022-12-31: -23638047 U001 Inspect Operating Income Open source 2022-01-01 – 2022-12-31: -23290657 U001 Inspect Net Income Open source 2022-01-01 – 2022-12-31: -12693953 U001 Inspect Operating Cash Flow Open source

Amounts are exact, in U001.

Growth

Sales over time and how quickly they are changing.

Revenue

Revenue reported for each complete financial period.

U001 49.5M 2022

Values and sources

Revenue values and source evidence
Period	Series	Value(U001)	Source evidence
20132013-12-31	Revenue	29549609	Revenue: 29549609 Open source
20142014-12-31	Revenue	27645284	Revenue: 27645284 Open source
20152015-12-31	Revenue	24255485	Revenue: 24255485 Open source
20162016-12-31	Revenue	17868841	Revenue: 17868841 Open source
20172017-12-31	Revenue	24015427	Revenue: 24015427 Open source
20182018-12-31	Revenue	34581440	Revenue: 34581440 Open source
20192019-12-31	Revenue	34464032	Revenue: 34464032 Open source
20202020-12-31	Revenue	32470197	Revenue: 32470197 Open source
20212021-12-31	Revenue	47818452	Revenue: 47818452 Open source
20222022-12-31	Revenue	49521923	Revenue: 49521923 Open source

Revenue growth

Change in revenue from the same financial period one year earlier.

3.6% 2022

Values and sources

Revenue growth values and source evidence
Period	Series	Value	Source evidence
20132013-12-31	Year over year	15.4%	Revenue: 29549609 Open source Revenue: 25610595 Open source
20142014-12-31	Year over year	-6.4%	Revenue: 27645284 Open source Revenue: 29549609 Open source
20152015-12-31	Year over year	-12.3%	Revenue: 24255485 Open source Revenue: 27645284 Open source
20162016-12-31	Year over year	-26.3%	Revenue: 17868841 Open source Revenue: 24255485 Open source
20172017-12-31	Year over year	34.4%	Revenue: 24015427 Open source Revenue: 17868841 Open source
20182018-12-31	Year over year	44%	Revenue: 34581440 Open source Revenue: 24015427 Open source
20192019-12-31	Year over year	-0.3%	Revenue: 34464032 Open source Revenue: 34581440 Open source
20202020-12-31	Year over year	-5.8%	Revenue: 32470197 Open source Revenue: 34464032 Open source
20212021-12-31	Year over year	47.3%	Revenue: 47818452 Open source Revenue: 32470197 Open source
20222022-12-31	Year over year	3.6%	Revenue: 49521923 Open source Revenue: 47818452 Open source

Profit and cash

How much revenue becomes profit, and how much cash operations generate.

Profit margins

Operating income, net income and free cash flow as a share of revenue.

Operating margin -47.7% 2022

Net margin -47% 2022

Free cash flow margin -68.4% 2021

Operating margin
Net margin
Free cash flow margin

Values and sources

Profit margins values and source evidence
Period	Series	Value	Source evidence
20132013-12-31	Operating margin	3.4%	Operating Income: 1004827 Open source Revenue: 29549609 Open source
20142014-12-31	Operating margin	-5.6%	Operating Income: -1550253 Open source Revenue: 27645284 Open source
20152015-12-31	Operating margin	-14.7%	Operating Income: -3554047 Open source Revenue: 24255485 Open source
20162016-12-31	Operating margin	-42.4%	Operating Income: -7571777 Open source Revenue: 17868841 Open source
20172017-12-31	Operating margin	-27%	Operating Income: -6482550 Open source Revenue: 24015427 Open source
20182018-12-31	Operating margin	-23.1%	Operating Income: -7982668 Open source Revenue: 34581440 Open source
20192019-12-31	Operating margin	-38.7%	Operating Income: -13328590 Open source Revenue: 34464032 Open source
20202020-12-31	Operating margin	-71.3%	Operating Income: -23136292 Open source Revenue: 32470197 Open source
20212021-12-31	Operating margin	-64.9%	Operating Income: -31053164 Open source Revenue: 47818452 Open source
20222022-12-31	Operating margin	-47.7%	Operating Income: -23638047 Open source Revenue: 49521923 Open source
20132013-12-31	Net margin	1.8%	Net Income: 530818 Open source Revenue: 29549609 Open source
20142014-12-31	Net margin	-4.1%	Net Income: -1137203 Open source Revenue: 27645284 Open source
20152015-12-31	Net margin	-9.9%	Net Income: -2397042 Open source Revenue: 24255485 Open source
20162016-12-31	Net margin	-74.7%	Net Income: -13347047 Open source Revenue: 17868841 Open source
20172017-12-31	Net margin	-26.5%	Net Income: -6371760 Open source Revenue: 24015427 Open source
20182018-12-31	Net margin	-22.7%	Net Income: -7865649 Open source Revenue: 34581440 Open source
20192019-12-31	Net margin	-39.7%	Net Income: -13675129 Open source Revenue: 34464032 Open source
20202020-12-31	Net margin	-78.6%	Net Income: -25521328 Open source Revenue: 32470197 Open source
20212021-12-31	Net margin	-70.9%	Net Income: -33903529 Open source Revenue: 47818452 Open source
20222022-12-31	Net margin	-47%	Net Income: -23290657 Open source Revenue: 49521923 Open source
20132013-12-31	Free cash flow margin	4.7%	Revenue: 29549609 Open source Operating Cash Flow: 2277614 Open source Capital Expenditure: 885609 Open source
20142014-12-31	Free cash flow margin	-19.1%	Revenue: 27645284 Open source Operating Cash Flow: -3820299 Open source Capital Expenditure: 1452601 Open source
20152015-12-31	Free cash flow margin	5.4%	Revenue: 24255485 Open source Operating Cash Flow: 1792978 Open source Capital Expenditure: 480585 Open source
20162016-12-31	Free cash flow margin	-38.2%	Revenue: 17868841 Open source Operating Cash Flow: -6704734 Open source Capital Expenditure: 118706 Open source
20172017-12-31	Free cash flow margin	-25.2%	Revenue: 24015427 Open source Operating Cash Flow: -5034515 Open source Capital Expenditure: 1026954 Open source
20182018-12-31	Free cash flow margin	-38.3%	Revenue: 34581440 Open source Operating Cash Flow: -11781441 Open source Capital Expenditure: 1467192 Open source
20192019-12-31	Free cash flow margin	-36.4%	Revenue: 34464032 Open source Operating Cash Flow: -9055506 Open source Capital Expenditure: 3502540 Open source
20202020-12-31	Free cash flow margin	-70.4%	Revenue: 32470197 Open source Operating Cash Flow: -18887238 Open source Capital Expenditure: 3961369 Open source
20212021-12-31	Free cash flow margin	-68.4%	Revenue: 47818452 Open source Operating Cash Flow: -30885716 Open source Capital Expenditure: 1824285 Open source
20222022-12-31	Free cash flow margin	Not reported	Revenue: 49521923 Open source Operating Cash Flow: -12693953 Open source

Operating cash flow

Cash generated by the company’s normal business operations.

U001 -12.7M 2022

Values and sources

Operating cash flow values and source evidence
Period	Series	Value(U001)	Source evidence
20132013-12-31	Operating cash flow	2277614	Operating Cash Flow: 2277614 Open source
20142014-12-31	Operating cash flow	-3820299	Operating Cash Flow: -3820299 Open source
20152015-12-31	Operating cash flow	1792978	Operating Cash Flow: 1792978 Open source
20162016-12-31	Operating cash flow	-6704734	Operating Cash Flow: -6704734 Open source
20172017-12-31	Operating cash flow	-5034515	Operating Cash Flow: -5034515 Open source
20182018-12-31	Operating cash flow	-11781441	Operating Cash Flow: -11781441 Open source
20192019-12-31	Operating cash flow	-9055506	Operating Cash Flow: -9055506 Open source
20202020-12-31	Operating cash flow	-18887238	Operating Cash Flow: -18887238 Open source
20212021-12-31	Operating cash flow	-30885716	Operating Cash Flow: -30885716 Open source
20222022-12-31	Operating cash flow	-12693953	Operating Cash Flow: -12693953 Open source

Free cash flow

Operating cash flow minus capital expenditure for the same period and unit.

U001 -32.7M 2021

Values and sources

Free cash flow values and source evidence
Period	Series	Value(U001)	Source evidence
20132013-12-31	Free cash flow	1392005	Operating Cash Flow: 2277614 Open source Capital Expenditure: 885609 Open source
20142014-12-31	Free cash flow	-5272900	Operating Cash Flow: -3820299 Open source Capital Expenditure: 1452601 Open source
20152015-12-31	Free cash flow	1312393	Operating Cash Flow: 1792978 Open source Capital Expenditure: 480585 Open source
20162016-12-31	Free cash flow	-6823440	Operating Cash Flow: -6704734 Open source Capital Expenditure: 118706 Open source
20172017-12-31	Free cash flow	-6061469	Operating Cash Flow: -5034515 Open source Capital Expenditure: 1026954 Open source
20182018-12-31	Free cash flow	-13248633	Operating Cash Flow: -11781441 Open source Capital Expenditure: 1467192 Open source
20192019-12-31	Free cash flow	-12558046	Operating Cash Flow: -9055506 Open source Capital Expenditure: 3502540 Open source
20202020-12-31	Free cash flow	-22848607	Operating Cash Flow: -18887238 Open source Capital Expenditure: 3961369 Open source
20212021-12-31	Free cash flow	-32710001	Operating Cash Flow: -30885716 Open source Capital Expenditure: 1824285 Open source
20222022-12-31	Free cash flow	Unavailable	Operating Cash Flow: -12693953 Open source

Balance sheet

Liabilities and short-term ability to meet obligations at each period end.

Liabilities to assets

Total liabilities as a share of total assets.

71.6% 2022

Values and sources

Liabilities to assets values and source evidence
Period	Series	Value	Source evidence
20132013-12-31	Liabilities / assets	17.6%	Total Liabilities: 4309490 Open source Total Assets: 24486592 Open source
20142014-12-31	Liabilities / assets	21.1%	Total Liabilities: 5286030 Open source Total Assets: 25010192 Open source
20152015-12-31	Liabilities / assets	15.2%	Total Liabilities: 3154838 Open source Total Assets: 20816344 Open source
20162016-12-31	Liabilities / assets	16.6%	Total Liabilities: 3405650 Open source Total Assets: 20575236 Open source
20172017-12-31	Liabilities / assets	21.3%	Total Liabilities: 3536825 Open source Total Assets: 16616021 Open source
20182018-12-31	Liabilities / assets	18.5%	Total Liabilities: 7583409 Open source Total Assets: 40911183 Open source
20192019-12-31	Liabilities / assets	56.9%	Total Liabilities: 31693711 Open source Total Assets: 55728964 Open source
20202020-12-31	Liabilities / assets	57.2%	Total Liabilities: 37115605 Open source Total Assets: 64892014 Open source
20212021-12-31	Liabilities / assets	53.2%	Total Liabilities: 38987295 Open source Total Assets: 73252195 Open source
20222022-12-31	Liabilities / assets	71.6%	Total Liabilities: 44813048 Open source Total Assets: 62611405 Open source

Current assets to current liabilities

Current assets divided by current liabilities.

1.23× 2022

Values and sources

Current assets to current liabilities values and source evidence
Period	Series	Value	Source evidence
20132013-12-31	Current assets / current liabilities	4.3×	Current Assets: 18530501 Open source Current Liabilities: 4309490 Open source
20142014-12-31	Current assets / current liabilities	3.34×	Current Assets: 17658199 Open source Current Liabilities: 5286030 Open source
20152015-12-31	Current assets / current liabilities	4×	Current Assets: 12634806 Open source Current Liabilities: 3154838 Open source
20162016-12-31	Current assets / current liabilities	5.32×	Current Assets: 18113526 Open source Current Liabilities: 3405650 Open source
20172017-12-31	Current assets / current liabilities	3.51×	Current Assets: 10853643 Open source Current Liabilities: 3096303 Open source
20182018-12-31	Current assets / current liabilities	4.36×	Current Assets: 28451754 Open source Current Liabilities: 6519280 Open source
20192019-12-31	Current assets / current liabilities	5×	Current Assets: 32223720 Open source Current Liabilities: 6441680 Open source
20202020-12-31	Current assets / current liabilities	3.22×	Current Assets: 39738773 Open source Current Liabilities: 12351124 Open source
20212021-12-31	Current assets / current liabilities	3.59×	Current Assets: 54844644 Open source Current Liabilities: 15282463 Open source
20222022-12-31	Current assets / current liabilities	1.23×	Current Assets: 48451695 Open source Current Liabilities: 39300116 Open source

Cash generation

Compare reported profit with operating cash and capital spending. Free cash flow is calculated as operating cash flow minus capital expenditure when both exact, consolidated amounts match the same period and unit.

Cash generation by annual reporting period
Period	Net income	Operating cash flow	Capital expenditure	Free cash flow
2013 2013-01-01 – 2013-12-31	U001 530,818 Exact value Exact value: 530818 U001 2013-01-01 – 2013-12-31: 530818 U001 Inspect Net Income Open source Share or cite Citation for Net Income · Chembio Diagnostics, Inc. · 2013-12-31 Chembio Diagnostics, Inc. (edgar:1092662) Net Income: 530818 U001 Concept: fundies:NetIncome Period: 2013-01-01 to 2013-12-31 Values: Latest reported Published: 2026-11-02T09:19:19Z Snapshot: 3e30444a4216581077c44f423ce8be06ef2be4055b160acf7d3e4d2760732832 Dimensions: Consolidated View: https://fundies.io/companies/edgar/1092662/explain?concept=fundies%3ANetIncome&period=2013-12-31&surface=latest&period_type=duration&start=2013-01-01&unit=U001&dimensions= Input fundies:NetIncome: 530818 U001 (2013-01-01 to 2013-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1092662/000109266215000024/cemi-20141231.xml#423084 Filing: 000109266215000024 The citation records this snapshot. The page link may show a newer release later.	U001 2.28 million Exact value Exact value: 2277614 U001 2013-01-01 – 2013-12-31: 2277614 U001 Inspect Operating Cash Flow Open source Share or cite Citation for Operating Cash Flow · Chembio Diagnostics, Inc. · 2013-12-31 Chembio Diagnostics, Inc. (edgar:1092662) Operating Cash Flow: 2277614 U001 Concept: fundies:OperatingCashFlow Period: 2013-01-01 to 2013-12-31 Values: Latest reported Published: 2026-11-02T09:19:19Z Snapshot: 3e30444a4216581077c44f423ce8be06ef2be4055b160acf7d3e4d2760732832 Dimensions: Consolidated View: https://fundies.io/companies/edgar/1092662/explain?concept=fundies%3AOperatingCashFlow&period=2013-12-31&surface=latest&period_type=duration&start=2013-01-01&unit=U001&dimensions= Input fundies:OperatingCashFlow: 2277614 U001 (2013-01-01 to 2013-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1092662/000109266215000024/cemi-20141231.xml#425506 Filing: 000109266215000024 The citation records this snapshot. The page link may show a newer release later.	U001 885,609 Exact value Exact value: 885609 U001 2013-01-01 – 2013-12-31: 885609 U001 Inspect Capital Expenditure Open source Share or cite Citation for Capital Expenditure · Chembio Diagnostics, Inc. · 2013-12-31 Chembio Diagnostics, Inc. (edgar:1092662) Capital Expenditure: 885609 U001 Concept: fundies:CapitalExpenditure Period: 2013-01-01 to 2013-12-31 Values: Latest reported Published: 2026-11-02T09:19:19Z Snapshot: 3e30444a4216581077c44f423ce8be06ef2be4055b160acf7d3e4d2760732832 Dimensions: Consolidated View: https://fundies.io/companies/edgar/1092662/explain?concept=fundies%3ACapitalExpenditure&period=2013-12-31&surface=latest&period_type=duration&start=2013-01-01&unit=U001&dimensions= Input fundies:CapitalExpenditure: 885609 U001 (2013-01-01 to 2013-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1092662/000109266215000024/cemi-20141231.xml#437335 Filing: 000109266215000024 The citation records this snapshot. The page link may show a newer release later.	U001 1.39 million Calculation and evidence 2277614 − 885609 U001 Exact free cash flow: 1392005 U001 2013-01-01 – 2013-12-31: 2277614 U001 · Inspect Operating Cash Flow · Source 2013-01-01 – 2013-12-31: 885609 U001 · Inspect Capital Expenditure · Source Share or cite Citation for Free cash flow · Chembio Diagnostics, Inc. · 2013-12-31 Chembio Diagnostics, Inc. (edgar:1092662) Free cash flow: 1392005 U001 Concept: free-cash-flow Period: 2013-01-01 to 2013-12-31 Values: Latest reported Published: 2026-11-02T09:19:19Z Snapshot: 3e30444a4216581077c44f423ce8be06ef2be4055b160acf7d3e4d2760732832 Dimensions: Consolidated View: https://fundies.io/companies/edgar/1092662?view=overview&cadence=annual&surface=latest#cash-generation-title Computed: Operating cash flow minus capital expenditure Input fundies:OperatingCashFlow: 2277614 U001 (2013-01-01 to 2013-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1092662/000109266215000024/cemi-20141231.xml#425506 Filing: 000109266215000024 Input fundies:CapitalExpenditure: 885609 U001 (2013-01-01 to 2013-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1092662/000109266215000024/cemi-20141231.xml#437335 Filing: 000109266215000024 The citation records this snapshot. The page link may show a newer release later.
2014 2014-01-01 – 2014-12-31	−U001 1.14 million Exact value Exact value: -1137203 U001 2014-01-01 – 2014-12-31: -1137203 U001 Inspect Net Income Open source Share or cite Citation for Net Income · Chembio Diagnostics, Inc. · 2014-12-31 Chembio Diagnostics, Inc. (edgar:1092662) Net Income: -1137203 U001 Concept: fundies:NetIncome Period: 2014-01-01 to 2014-12-31 Values: Latest reported Published: 2026-11-02T09:19:19Z Snapshot: 3e30444a4216581077c44f423ce8be06ef2be4055b160acf7d3e4d2760732832 Dimensions: Consolidated View: https://fundies.io/companies/edgar/1092662/explain?concept=fundies%3ANetIncome&period=2014-12-31&surface=latest&period_type=duration&start=2014-01-01&unit=U001&dimensions= Input fundies:NetIncome: -1137203 U001 (2014-01-01 to 2014-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1092662/000109266217000023/cemi-20161231.xml#500998 Filing: 000109266217000023 The citation records this snapshot. The page link may show a newer release later.	−U001 3.82 million Exact value Exact value: -3820299 U001 2014-01-01 – 2014-12-31: -3820299 U001 Inspect Operating Cash Flow Open source Share or cite Citation for Operating Cash Flow · Chembio Diagnostics, Inc. · 2014-12-31 Chembio Diagnostics, Inc. (edgar:1092662) Operating Cash Flow: -3820299 U001 Concept: fundies:OperatingCashFlow Period: 2014-01-01 to 2014-12-31 Values: Latest reported Published: 2026-11-02T09:19:19Z Snapshot: 3e30444a4216581077c44f423ce8be06ef2be4055b160acf7d3e4d2760732832 Dimensions: Consolidated View: https://fundies.io/companies/edgar/1092662/explain?concept=fundies%3AOperatingCashFlow&period=2014-12-31&surface=latest&period_type=duration&start=2014-01-01&unit=U001&dimensions= Input fundies:OperatingCashFlow: -3820299 U001 (2014-01-01 to 2014-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1092662/000109266217000023/cemi-20161231.xml#500763 Filing: 000109266217000023 The citation records this snapshot. The page link may show a newer release later.	U001 1.45 million Exact value Exact value: 1452601 U001 2014-01-01 – 2014-12-31: 1452601 U001 Inspect Capital Expenditure Open source Share or cite Citation for Capital Expenditure · Chembio Diagnostics, Inc. · 2014-12-31 Chembio Diagnostics, Inc. (edgar:1092662) Capital Expenditure: 1452601 U001 Concept: fundies:CapitalExpenditure Period: 2014-01-01 to 2014-12-31 Values: Latest reported Published: 2026-11-02T09:19:19Z Snapshot: 3e30444a4216581077c44f423ce8be06ef2be4055b160acf7d3e4d2760732832 Dimensions: Consolidated View: https://fundies.io/companies/edgar/1092662/explain?concept=fundies%3ACapitalExpenditure&period=2014-12-31&surface=latest&period_type=duration&start=2014-01-01&unit=U001&dimensions= Input fundies:CapitalExpenditure: 1452601 U001 (2014-01-01 to 2014-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1092662/000109266217000023/cemi-20161231.xml#520335 Filing: 000109266217000023 The citation records this snapshot. The page link may show a newer release later.	−U001 5.27 million Calculation and evidence -3820299 − 1452601 U001 Exact free cash flow: -5272900 U001 2014-01-01 – 2014-12-31: -3820299 U001 · Inspect Operating Cash Flow · Source 2014-01-01 – 2014-12-31: 1452601 U001 · Inspect Capital Expenditure · Source Share or cite Citation for Free cash flow · Chembio Diagnostics, Inc. · 2014-12-31 Chembio Diagnostics, Inc. (edgar:1092662) Free cash flow: -5272900 U001 Concept: free-cash-flow Period: 2014-01-01 to 2014-12-31 Values: Latest reported Published: 2026-11-02T09:19:19Z Snapshot: 3e30444a4216581077c44f423ce8be06ef2be4055b160acf7d3e4d2760732832 Dimensions: Consolidated View: https://fundies.io/companies/edgar/1092662?view=overview&cadence=annual&surface=latest#cash-generation-title Computed: Operating cash flow minus capital expenditure Input fundies:OperatingCashFlow: -3820299 U001 (2014-01-01 to 2014-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1092662/000109266217000023/cemi-20161231.xml#500763 Filing: 000109266217000023 Input fundies:CapitalExpenditure: 1452601 U001 (2014-01-01 to 2014-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1092662/000109266217000023/cemi-20161231.xml#520335 Filing: 000109266217000023 The citation records this snapshot. The page link may show a newer release later.
2015 2015-01-01 – 2015-12-31	−U001 2.4 million Exact value Exact value: -2397042 U001 2015-01-01 – 2015-12-31: -2397042 U001 Inspect Net Income Open source Share or cite Citation for Net Income · Chembio Diagnostics, Inc. · 2015-12-31 Chembio Diagnostics, Inc. (edgar:1092662) Net Income: -2397042 U001 Concept: fundies:NetIncome Period: 2015-01-01 to 2015-12-31 Values: Latest reported Published: 2026-11-02T09:19:19Z Snapshot: 3e30444a4216581077c44f423ce8be06ef2be4055b160acf7d3e4d2760732832 Dimensions: Consolidated View: https://fundies.io/companies/edgar/1092662/explain?concept=fundies%3ANetIncome&period=2015-12-31&surface=latest&period_type=duration&start=2015-01-01&unit=U001&dimensions= Input fundies:NetIncome: -2397042 U001 (2015-01-01 to 2015-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1092662/000109266218000013/cemi-20171231.xml#636369 Filing: 000109266218000013 The citation records this snapshot. The page link may show a newer release later.	U001 1.79 million Exact value Exact value: 1792978 U001 2015-01-01 – 2015-12-31: 1792978 U001 Inspect Operating Cash Flow Open source Share or cite Citation for Operating Cash Flow · Chembio Diagnostics, Inc. · 2015-12-31 Chembio Diagnostics, Inc. (edgar:1092662) Operating Cash Flow: 1792978 U001 Concept: fundies:OperatingCashFlow Period: 2015-01-01 to 2015-12-31 Values: Latest reported Published: 2026-11-02T09:19:19Z Snapshot: 3e30444a4216581077c44f423ce8be06ef2be4055b160acf7d3e4d2760732832 Dimensions: Consolidated View: https://fundies.io/companies/edgar/1092662/explain?concept=fundies%3AOperatingCashFlow&period=2015-12-31&surface=latest&period_type=duration&start=2015-01-01&unit=U001&dimensions= Input fundies:OperatingCashFlow: 1792978 U001 (2015-01-01 to 2015-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1092662/000109266218000013/cemi-20171231.xml#634145 Filing: 000109266218000013 The citation records this snapshot. The page link may show a newer release later.	U001 480,585 Exact value Exact value: 480585 U001 2015-01-01 – 2015-12-31: 480585 U001 Inspect Capital Expenditure Open source Share or cite Citation for Capital Expenditure · Chembio Diagnostics, Inc. · 2015-12-31 Chembio Diagnostics, Inc. (edgar:1092662) Capital Expenditure: 480585 U001 Concept: fundies:CapitalExpenditure Period: 2015-01-01 to 2015-12-31 Values: Latest reported Published: 2026-11-02T09:19:19Z Snapshot: 3e30444a4216581077c44f423ce8be06ef2be4055b160acf7d3e4d2760732832 Dimensions: Consolidated View: https://fundies.io/companies/edgar/1092662/explain?concept=fundies%3ACapitalExpenditure&period=2015-12-31&surface=latest&period_type=duration&start=2015-01-01&unit=U001&dimensions= Input fundies:CapitalExpenditure: 480585 U001 (2015-01-01 to 2015-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1092662/000109266218000013/cemi-20171231.xml#662205 Filing: 000109266218000013 The citation records this snapshot. The page link may show a newer release later.	U001 1.31 million Calculation and evidence 1792978 − 480585 U001 Exact free cash flow: 1312393 U001 2015-01-01 – 2015-12-31: 1792978 U001 · Inspect Operating Cash Flow · Source 2015-01-01 – 2015-12-31: 480585 U001 · Inspect Capital Expenditure · Source Share or cite Citation for Free cash flow · Chembio Diagnostics, Inc. · 2015-12-31 Chembio Diagnostics, Inc. (edgar:1092662) Free cash flow: 1312393 U001 Concept: free-cash-flow Period: 2015-01-01 to 2015-12-31 Values: Latest reported Published: 2026-11-02T09:19:19Z Snapshot: 3e30444a4216581077c44f423ce8be06ef2be4055b160acf7d3e4d2760732832 Dimensions: Consolidated View: https://fundies.io/companies/edgar/1092662?view=overview&cadence=annual&surface=latest#cash-generation-title Computed: Operating cash flow minus capital expenditure Input fundies:OperatingCashFlow: 1792978 U001 (2015-01-01 to 2015-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1092662/000109266218000013/cemi-20171231.xml#634145 Filing: 000109266218000013 Input fundies:CapitalExpenditure: 480585 U001 (2015-01-01 to 2015-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1092662/000109266218000013/cemi-20171231.xml#662205 Filing: 000109266218000013 The citation records this snapshot. The page link may show a newer release later.
2016 2016-01-01 – 2016-12-31	−U001 13.35 million Exact value Exact value: -13347047 U001 2016-01-01 – 2016-12-31: -13347047 U001 Inspect Net Income Open source Share or cite Citation for Net Income · Chembio Diagnostics, Inc. · 2016-12-31 Chembio Diagnostics, Inc. (edgar:1092662) Net Income: -13347047 U001 Concept: fundies:NetIncome Period: 2016-01-01 to 2016-12-31 Values: Latest reported Published: 2026-11-02T09:19:19Z Snapshot: 3e30444a4216581077c44f423ce8be06ef2be4055b160acf7d3e4d2760732832 Dimensions: Consolidated View: https://fundies.io/companies/edgar/1092662/explain?concept=fundies%3ANetIncome&period=2016-12-31&surface=latest&period_type=duration&start=2016-01-01&unit=U001&dimensions= Input fundies:NetIncome: -13347047 U001 (2016-01-01 to 2016-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1092662/000109266218000013/cemi-20171231.xml#636643 Filing: 000109266218000013 The citation records this snapshot. The page link may show a newer release later.	−U001 6.7 million Exact value Exact value: -6704734 U001 2016-01-01 – 2016-12-31: -6704734 U001 Inspect Operating Cash Flow Open source Share or cite Citation for Operating Cash Flow · Chembio Diagnostics, Inc. · 2016-12-31 Chembio Diagnostics, Inc. (edgar:1092662) Operating Cash Flow: -6704734 U001 Concept: fundies:OperatingCashFlow Period: 2016-01-01 to 2016-12-31 Values: Latest reported Published: 2026-11-02T09:19:19Z Snapshot: 3e30444a4216581077c44f423ce8be06ef2be4055b160acf7d3e4d2760732832 Dimensions: Consolidated View: https://fundies.io/companies/edgar/1092662/explain?concept=fundies%3AOperatingCashFlow&period=2016-12-31&surface=latest&period_type=duration&start=2016-01-01&unit=U001&dimensions= Input fundies:OperatingCashFlow: -6704734 U001 (2016-01-01 to 2016-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1092662/000109266218000013/cemi-20171231.xml#633669 Filing: 000109266218000013 The citation records this snapshot. The page link may show a newer release later.	U001 118,706 Exact value Exact value: 118706 U001 2016-01-01 – 2016-12-31: 118706 U001 Inspect Capital Expenditure Open source Share or cite Citation for Capital Expenditure · Chembio Diagnostics, Inc. · 2016-12-31 Chembio Diagnostics, Inc. (edgar:1092662) Capital Expenditure: 118706 U001 Concept: fundies:CapitalExpenditure Period: 2016-01-01 to 2016-12-31 Values: Latest reported Published: 2026-11-02T09:19:19Z Snapshot: 3e30444a4216581077c44f423ce8be06ef2be4055b160acf7d3e4d2760732832 Dimensions: Consolidated View: https://fundies.io/companies/edgar/1092662/explain?concept=fundies%3ACapitalExpenditure&period=2016-12-31&surface=latest&period_type=duration&start=2016-01-01&unit=U001&dimensions= Input fundies:CapitalExpenditure: 118706 U001 (2016-01-01 to 2016-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1092662/000109266218000013/cemi-20171231.xml#662440 Filing: 000109266218000013 The citation records this snapshot. The page link may show a newer release later.	−U001 6.82 million Calculation and evidence -6704734 − 118706 U001 Exact free cash flow: -6823440 U001 2016-01-01 – 2016-12-31: -6704734 U001 · Inspect Operating Cash Flow · Source 2016-01-01 – 2016-12-31: 118706 U001 · Inspect Capital Expenditure · Source Share or cite Citation for Free cash flow · Chembio Diagnostics, Inc. · 2016-12-31 Chembio Diagnostics, Inc. (edgar:1092662) Free cash flow: -6823440 U001 Concept: free-cash-flow Period: 2016-01-01 to 2016-12-31 Values: Latest reported Published: 2026-11-02T09:19:19Z Snapshot: 3e30444a4216581077c44f423ce8be06ef2be4055b160acf7d3e4d2760732832 Dimensions: Consolidated View: https://fundies.io/companies/edgar/1092662?view=overview&cadence=annual&surface=latest#cash-generation-title Computed: Operating cash flow minus capital expenditure Input fundies:OperatingCashFlow: -6704734 U001 (2016-01-01 to 2016-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1092662/000109266218000013/cemi-20171231.xml#633669 Filing: 000109266218000013 Input fundies:CapitalExpenditure: 118706 U001 (2016-01-01 to 2016-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1092662/000109266218000013/cemi-20171231.xml#662440 Filing: 000109266218000013 The citation records this snapshot. The page link may show a newer release later.
2017 2017-01-01 – 2017-12-31	−U001 6.37 million Exact value Exact value: -6371760 U001 2017-01-01 – 2017-12-31: -6371760 U001 Inspect Net Income Open source Share or cite Citation for Net Income · Chembio Diagnostics, Inc. · 2017-12-31 Chembio Diagnostics, Inc. (edgar:1092662) Net Income: -6371760 U001 Concept: fundies:NetIncome Period: 2017-01-01 to 2017-12-31 Values: Latest reported Published: 2026-11-02T09:19:19Z Snapshot: 3e30444a4216581077c44f423ce8be06ef2be4055b160acf7d3e4d2760732832 Dimensions: Consolidated View: https://fundies.io/companies/edgar/1092662/explain?concept=fundies%3ANetIncome&period=2017-12-31&surface=latest&period_type=duration&start=2017-01-01&unit=U001&dimensions= Input fundies:NetIncome: -6371760 U001 (2017-01-01 to 2017-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1092662/000114036119005069/cemi-20181231.xml#798247 Filing: 000114036119005069 The citation records this snapshot. The page link may show a newer release later.	−U001 5.03 million Exact value Exact value: -5034515 U001 2017-01-01 – 2017-12-31: -5034515 U001 Inspect Operating Cash Flow Open source Share or cite Citation for Operating Cash Flow · Chembio Diagnostics, Inc. · 2017-12-31 Chembio Diagnostics, Inc. (edgar:1092662) Operating Cash Flow: -5034515 U001 Concept: fundies:OperatingCashFlow Period: 2017-01-01 to 2017-12-31 Values: Latest reported Published: 2026-11-02T09:19:19Z Snapshot: 3e30444a4216581077c44f423ce8be06ef2be4055b160acf7d3e4d2760732832 Dimensions: Consolidated View: https://fundies.io/companies/edgar/1092662/explain?concept=fundies%3AOperatingCashFlow&period=2017-12-31&surface=latest&period_type=duration&start=2017-01-01&unit=U001&dimensions= Input fundies:OperatingCashFlow: -5034515 U001 (2017-01-01 to 2017-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1092662/000114036119005069/cemi-20181231.xml#797676 Filing: 000114036119005069 The citation records this snapshot. The page link may show a newer release later.	U001 1.03 million Exact value Exact value: 1026954 U001 2017-01-01 – 2017-12-31: 1026954 U001 Inspect Capital Expenditure Open source Share or cite Citation for Capital Expenditure · Chembio Diagnostics, Inc. · 2017-12-31 Chembio Diagnostics, Inc. (edgar:1092662) Capital Expenditure: 1026954 U001 Concept: fundies:CapitalExpenditure Period: 2017-01-01 to 2017-12-31 Values: Latest reported Published: 2026-11-02T09:19:19Z Snapshot: 3e30444a4216581077c44f423ce8be06ef2be4055b160acf7d3e4d2760732832 Dimensions: Consolidated View: https://fundies.io/companies/edgar/1092662/explain?concept=fundies%3ACapitalExpenditure&period=2017-12-31&surface=latest&period_type=duration&start=2017-01-01&unit=U001&dimensions= Input fundies:CapitalExpenditure: 1026954 U001 (2017-01-01 to 2017-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1092662/000114036119005069/cemi-20181231.xml#827313 Filing: 000114036119005069 The citation records this snapshot. The page link may show a newer release later.	−U001 6.06 million Calculation and evidence -5034515 − 1026954 U001 Exact free cash flow: -6061469 U001 2017-01-01 – 2017-12-31: -5034515 U001 · Inspect Operating Cash Flow · Source 2017-01-01 – 2017-12-31: 1026954 U001 · Inspect Capital Expenditure · Source Share or cite Citation for Free cash flow · Chembio Diagnostics, Inc. · 2017-12-31 Chembio Diagnostics, Inc. (edgar:1092662) Free cash flow: -6061469 U001 Concept: free-cash-flow Period: 2017-01-01 to 2017-12-31 Values: Latest reported Published: 2026-11-02T09:19:19Z Snapshot: 3e30444a4216581077c44f423ce8be06ef2be4055b160acf7d3e4d2760732832 Dimensions: Consolidated View: https://fundies.io/companies/edgar/1092662?view=overview&cadence=annual&surface=latest#cash-generation-title Computed: Operating cash flow minus capital expenditure Input fundies:OperatingCashFlow: -5034515 U001 (2017-01-01 to 2017-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1092662/000114036119005069/cemi-20181231.xml#797676 Filing: 000114036119005069 Input fundies:CapitalExpenditure: 1026954 U001 (2017-01-01 to 2017-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1092662/000114036119005069/cemi-20181231.xml#827313 Filing: 000114036119005069 The citation records this snapshot. The page link may show a newer release later.
2018 2018-01-01 – 2018-12-31	−U001 7.87 million Exact value Exact value: -7865649 U001 2018-01-01 – 2018-12-31: -7865649 U001 Inspect Net Income Open source Share or cite Citation for Net Income · Chembio Diagnostics, Inc. · 2018-12-31 Chembio Diagnostics, Inc. (edgar:1092662) Net Income: -7865649 U001 Concept: fundies:NetIncome Period: 2018-01-01 to 2018-12-31 Values: Latest reported Published: 2026-11-02T09:19:19Z Snapshot: 3e30444a4216581077c44f423ce8be06ef2be4055b160acf7d3e4d2760732832 Dimensions: Consolidated View: https://fundies.io/companies/edgar/1092662/explain?concept=fundies%3ANetIncome&period=2018-12-31&surface=latest&period_type=duration&start=2018-01-01&unit=U001&dimensions= Input fundies:NetIncome: -7865649 U001 (2018-01-01 to 2018-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1092662/000114036120005780/cemi-20191231.xml#821437 Filing: 000114036120005780 The citation records this snapshot. The page link may show a newer release later.	−U001 11.78 million Exact value Exact value: -11781441 U001 2018-01-01 – 2018-12-31: -11781441 U001 Inspect Operating Cash Flow Open source Share or cite Citation for Operating Cash Flow · Chembio Diagnostics, Inc. · 2018-12-31 Chembio Diagnostics, Inc. (edgar:1092662) Operating Cash Flow: -11781441 U001 Concept: fundies:OperatingCashFlow Period: 2018-01-01 to 2018-12-31 Values: Latest reported Published: 2026-11-02T09:19:19Z Snapshot: 3e30444a4216581077c44f423ce8be06ef2be4055b160acf7d3e4d2760732832 Dimensions: Consolidated View: https://fundies.io/companies/edgar/1092662/explain?concept=fundies%3AOperatingCashFlow&period=2018-12-31&surface=latest&period_type=duration&start=2018-01-01&unit=U001&dimensions= Input fundies:OperatingCashFlow: -11781441 U001 (2018-01-01 to 2018-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1092662/000114036120005780/cemi-20191231.xml#819893 Filing: 000114036120005780 The citation records this snapshot. The page link may show a newer release later.	U001 1.47 million Exact value Exact value: 1467192 U001 2018-01-01 – 2018-12-31: 1467192 U001 Inspect Capital Expenditure Open source Share or cite Citation for Capital Expenditure · Chembio Diagnostics, Inc. · 2018-12-31 Chembio Diagnostics, Inc. (edgar:1092662) Capital Expenditure: 1467192 U001 Concept: fundies:CapitalExpenditure Period: 2018-01-01 to 2018-12-31 Values: Latest reported Published: 2026-11-02T09:19:19Z Snapshot: 3e30444a4216581077c44f423ce8be06ef2be4055b160acf7d3e4d2760732832 Dimensions: Consolidated View: https://fundies.io/companies/edgar/1092662/explain?concept=fundies%3ACapitalExpenditure&period=2018-12-31&surface=latest&period_type=duration&start=2018-01-01&unit=U001&dimensions= Input fundies:CapitalExpenditure: 1467192 U001 (2018-01-01 to 2018-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1092662/000114036120005780/cemi-20191231.xml#847467 Filing: 000114036120005780 The citation records this snapshot. The page link may show a newer release later.	−U001 13.25 million Calculation and evidence -11781441 − 1467192 U001 Exact free cash flow: -13248633 U001 2018-01-01 – 2018-12-31: -11781441 U001 · Inspect Operating Cash Flow · Source 2018-01-01 – 2018-12-31: 1467192 U001 · Inspect Capital Expenditure · Source Share or cite Citation for Free cash flow · Chembio Diagnostics, Inc. · 2018-12-31 Chembio Diagnostics, Inc. (edgar:1092662) Free cash flow: -13248633 U001 Concept: free-cash-flow Period: 2018-01-01 to 2018-12-31 Values: Latest reported Published: 2026-11-02T09:19:19Z Snapshot: 3e30444a4216581077c44f423ce8be06ef2be4055b160acf7d3e4d2760732832 Dimensions: Consolidated View: https://fundies.io/companies/edgar/1092662?view=overview&cadence=annual&surface=latest#cash-generation-title Computed: Operating cash flow minus capital expenditure Input fundies:OperatingCashFlow: -11781441 U001 (2018-01-01 to 2018-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1092662/000114036120005780/cemi-20191231.xml#819893 Filing: 000114036120005780 Input fundies:CapitalExpenditure: 1467192 U001 (2018-01-01 to 2018-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1092662/000114036120005780/cemi-20191231.xml#847467 Filing: 000114036120005780 The citation records this snapshot. The page link may show a newer release later.
2019 2019-01-01 – 2019-12-31	−U001 13.68 million Exact value Exact value: -13675129 U001 2019-01-01 – 2019-12-31: -13675129 U001 Inspect Net Income Open source Share or cite Citation for Net Income · Chembio Diagnostics, Inc. · 2019-12-31 Chembio Diagnostics, Inc. (edgar:1092662) Net Income: -13675129 U001 Concept: fundies:NetIncome Period: 2019-01-01 to 2019-12-31 Values: Latest reported Published: 2026-11-02T09:19:19Z Snapshot: 3e30444a4216581077c44f423ce8be06ef2be4055b160acf7d3e4d2760732832 Dimensions: Consolidated View: https://fundies.io/companies/edgar/1092662/explain?concept=fundies%3ANetIncome&period=2019-12-31&surface=latest&period_type=duration&start=2019-01-01&unit=U001&dimensions= Input fundies:NetIncome: -13675129 U001 (2019-01-01 to 2019-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1092662/000114036121008210/brhc10021388_10k.htm#1220487 Filing: 000114036121008210 The citation records this snapshot. The page link may show a newer release later.	−U001 9.06 million Exact value Exact value: -9055506 U001 2019-01-01 – 2019-12-31: -9055506 U001 Inspect Operating Cash Flow Open source Share or cite Citation for Operating Cash Flow · Chembio Diagnostics, Inc. · 2019-12-31 Chembio Diagnostics, Inc. (edgar:1092662) Operating Cash Flow: -9055506 U001 Concept: fundies:OperatingCashFlow Period: 2019-01-01 to 2019-12-31 Values: Latest reported Published: 2026-11-02T09:19:19Z Snapshot: 3e30444a4216581077c44f423ce8be06ef2be4055b160acf7d3e4d2760732832 Dimensions: Consolidated View: https://fundies.io/companies/edgar/1092662/explain?concept=fundies%3AOperatingCashFlow&period=2019-12-31&surface=latest&period_type=duration&start=2019-01-01&unit=U001&dimensions= Input fundies:OperatingCashFlow: -9055506 U001 (2019-01-01 to 2019-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1092662/000114036121008210/brhc10021388_10k.htm#1247572 Filing: 000114036121008210 The citation records this snapshot. The page link may show a newer release later.	U001 3.5 million Exact value Exact value: 3502540 U001 2019-01-01 – 2019-12-31: 3502540 U001 Inspect Capital Expenditure Open source Share or cite Citation for Capital Expenditure · Chembio Diagnostics, Inc. · 2019-12-31 Chembio Diagnostics, Inc. (edgar:1092662) Capital Expenditure: 3502540 U001 Concept: fundies:CapitalExpenditure Period: 2019-01-01 to 2019-12-31 Values: Latest reported Published: 2026-11-02T09:19:19Z Snapshot: 3e30444a4216581077c44f423ce8be06ef2be4055b160acf7d3e4d2760732832 Dimensions: Consolidated View: https://fundies.io/companies/edgar/1092662/explain?concept=fundies%3ACapitalExpenditure&period=2019-12-31&surface=latest&period_type=duration&start=2019-01-01&unit=U001&dimensions= Input fundies:CapitalExpenditure: 3502540 U001 (2019-01-01 to 2019-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1092662/000114036121008210/brhc10021388_10k.htm#1174433 Filing: 000114036121008210 The citation records this snapshot. The page link may show a newer release later.	−U001 12.56 million Calculation and evidence -9055506 − 3502540 U001 Exact free cash flow: -12558046 U001 2019-01-01 – 2019-12-31: -9055506 U001 · Inspect Operating Cash Flow · Source 2019-01-01 – 2019-12-31: 3502540 U001 · Inspect Capital Expenditure · Source Share or cite Citation for Free cash flow · Chembio Diagnostics, Inc. · 2019-12-31 Chembio Diagnostics, Inc. (edgar:1092662) Free cash flow: -12558046 U001 Concept: free-cash-flow Period: 2019-01-01 to 2019-12-31 Values: Latest reported Published: 2026-11-02T09:19:19Z Snapshot: 3e30444a4216581077c44f423ce8be06ef2be4055b160acf7d3e4d2760732832 Dimensions: Consolidated View: https://fundies.io/companies/edgar/1092662?view=overview&cadence=annual&surface=latest#cash-generation-title Computed: Operating cash flow minus capital expenditure Input fundies:OperatingCashFlow: -9055506 U001 (2019-01-01 to 2019-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1092662/000114036121008210/brhc10021388_10k.htm#1247572 Filing: 000114036121008210 Input fundies:CapitalExpenditure: 3502540 U001 (2019-01-01 to 2019-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1092662/000114036121008210/brhc10021388_10k.htm#1174433 Filing: 000114036121008210 The citation records this snapshot. The page link may show a newer release later.
2020 2020-01-01 – 2020-12-31	−U001 25.52 million Exact value Exact value: -25521328 U001 2020-01-01 – 2020-12-31: -25521328 U001 Inspect Net Income Open source Share or cite Citation for Net Income · Chembio Diagnostics, Inc. · 2020-12-31 Chembio Diagnostics, Inc. (edgar:1092662) Net Income: -25521328 U001 Concept: fundies:NetIncome Period: 2020-01-01 to 2020-12-31 Values: Latest reported Published: 2026-11-02T09:19:19Z Snapshot: 3e30444a4216581077c44f423ce8be06ef2be4055b160acf7d3e4d2760732832 Dimensions: Consolidated View: https://fundies.io/companies/edgar/1092662/explain?concept=fundies%3ANetIncome&period=2020-12-31&surface=latest&period_type=duration&start=2020-01-01&unit=U001&dimensions= Input fundies:NetIncome: -25521328 U001 (2020-01-01 to 2020-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1092662/000114036122007735/brhc10034606_10k.htm#1313987 Filing: 000114036122007735 The citation records this snapshot. The page link may show a newer release later.	−U001 18.89 million Exact value Exact value: -18887238 U001 2020-01-01 – 2020-12-31: -18887238 U001 Inspect Operating Cash Flow Open source Share or cite Citation for Operating Cash Flow · Chembio Diagnostics, Inc. · 2020-12-31 Chembio Diagnostics, Inc. (edgar:1092662) Operating Cash Flow: -18887238 U001 Concept: fundies:OperatingCashFlow Period: 2020-01-01 to 2020-12-31 Values: Latest reported Published: 2026-11-02T09:19:19Z Snapshot: 3e30444a4216581077c44f423ce8be06ef2be4055b160acf7d3e4d2760732832 Dimensions: Consolidated View: https://fundies.io/companies/edgar/1092662/explain?concept=fundies%3AOperatingCashFlow&period=2020-12-31&surface=latest&period_type=duration&start=2020-01-01&unit=U001&dimensions= Input fundies:OperatingCashFlow: -18887238 U001 (2020-01-01 to 2020-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1092662/000114036122007735/brhc10034606_10k.htm#1344018 Filing: 000114036122007735 The citation records this snapshot. The page link may show a newer release later.	U001 3.96 million Exact value Exact value: 3961369 U001 2020-01-01 – 2020-12-31: 3961369 U001 Inspect Capital Expenditure Open source Share or cite Citation for Capital Expenditure · Chembio Diagnostics, Inc. · 2020-12-31 Chembio Diagnostics, Inc. (edgar:1092662) Capital Expenditure: 3961369 U001 Concept: fundies:CapitalExpenditure Period: 2020-01-01 to 2020-12-31 Values: Latest reported Published: 2026-11-02T09:19:19Z Snapshot: 3e30444a4216581077c44f423ce8be06ef2be4055b160acf7d3e4d2760732832 Dimensions: Consolidated View: https://fundies.io/companies/edgar/1092662/explain?concept=fundies%3ACapitalExpenditure&period=2020-12-31&surface=latest&period_type=duration&start=2020-01-01&unit=U001&dimensions= Input fundies:CapitalExpenditure: 3961369 U001 (2020-01-01 to 2020-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1092662/000114036122007735/brhc10034606_10k.htm#1272199 Filing: 000114036122007735 The citation records this snapshot. The page link may show a newer release later.	−U001 22.85 million Calculation and evidence -18887238 − 3961369 U001 Exact free cash flow: -22848607 U001 2020-01-01 – 2020-12-31: -18887238 U001 · Inspect Operating Cash Flow · Source 2020-01-01 – 2020-12-31: 3961369 U001 · Inspect Capital Expenditure · Source Share or cite Citation for Free cash flow · Chembio Diagnostics, Inc. · 2020-12-31 Chembio Diagnostics, Inc. (edgar:1092662) Free cash flow: -22848607 U001 Concept: free-cash-flow Period: 2020-01-01 to 2020-12-31 Values: Latest reported Published: 2026-11-02T09:19:19Z Snapshot: 3e30444a4216581077c44f423ce8be06ef2be4055b160acf7d3e4d2760732832 Dimensions: Consolidated View: https://fundies.io/companies/edgar/1092662?view=overview&cadence=annual&surface=latest#cash-generation-title Computed: Operating cash flow minus capital expenditure Input fundies:OperatingCashFlow: -18887238 U001 (2020-01-01 to 2020-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1092662/000114036122007735/brhc10034606_10k.htm#1344018 Filing: 000114036122007735 Input fundies:CapitalExpenditure: 3961369 U001 (2020-01-01 to 2020-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1092662/000114036122007735/brhc10034606_10k.htm#1272199 Filing: 000114036122007735 The citation records this snapshot. The page link may show a newer release later.
2021 2021-01-01 – 2021-12-31	−U001 33.9 million Exact value Exact value: -33903529 U001 2021-01-01 – 2021-12-31: -33903529 U001 Inspect Net Income Open source Share or cite Citation for Net Income · Chembio Diagnostics, Inc. · 2021-12-31 Chembio Diagnostics, Inc. (edgar:1092662) Net Income: -33903529 U001 Concept: fundies:NetIncome Period: 2021-01-01 to 2021-12-31 Values: Latest reported Published: 2026-11-02T09:19:19Z Snapshot: 3e30444a4216581077c44f423ce8be06ef2be4055b160acf7d3e4d2760732832 Dimensions: Consolidated View: https://fundies.io/companies/edgar/1092662/explain?concept=fundies%3ANetIncome&period=2021-12-31&surface=latest&period_type=duration&start=2021-01-01&unit=U001&dimensions= Input fundies:NetIncome: -33903529 U001 (2021-01-01 to 2021-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1092662/000114036123014526/brhc10050381_10k.htm#1661842 Filing: 000114036123014526 The citation records this snapshot. The page link may show a newer release later.	−U001 30.89 million Exact value Exact value: -30885716 U001 2021-01-01 – 2021-12-31: -30885716 U001 Inspect Operating Cash Flow Open source Share or cite Citation for Operating Cash Flow · Chembio Diagnostics, Inc. · 2021-12-31 Chembio Diagnostics, Inc. (edgar:1092662) Operating Cash Flow: -30885716 U001 Concept: fundies:OperatingCashFlow Period: 2021-01-01 to 2021-12-31 Values: Latest reported Published: 2026-11-02T09:19:19Z Snapshot: 3e30444a4216581077c44f423ce8be06ef2be4055b160acf7d3e4d2760732832 Dimensions: Consolidated View: https://fundies.io/companies/edgar/1092662/explain?concept=fundies%3AOperatingCashFlow&period=2021-12-31&surface=latest&period_type=duration&start=2021-01-01&unit=U001&dimensions= Input fundies:OperatingCashFlow: -30885716 U001 (2021-01-01 to 2021-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1092662/000114036123014526/brhc10050381_10k.htm#1696375 Filing: 000114036123014526 The citation records this snapshot. The page link may show a newer release later.	U001 1.82 million Exact value Exact value: 1824285 U001 2021-01-01 – 2021-12-31: 1824285 U001 Inspect Capital Expenditure Open source Share or cite Citation for Capital Expenditure · Chembio Diagnostics, Inc. · 2021-12-31 Chembio Diagnostics, Inc. (edgar:1092662) Capital Expenditure: 1824285 U001 Concept: fundies:CapitalExpenditure Period: 2021-01-01 to 2021-12-31 Values: Latest reported Published: 2026-11-02T09:19:19Z Snapshot: 3e30444a4216581077c44f423ce8be06ef2be4055b160acf7d3e4d2760732832 Dimensions: Consolidated View: https://fundies.io/companies/edgar/1092662/explain?concept=fundies%3ACapitalExpenditure&period=2021-12-31&surface=latest&period_type=duration&start=2021-01-01&unit=U001&dimensions= Input fundies:CapitalExpenditure: 1824285 U001 (2021-01-01 to 2021-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1092662/000114036122007735/brhc10034606_10k.htm#1271194 Filing: 000114036122007735 The citation records this snapshot. The page link may show a newer release later.	−U001 32.71 million Calculation and evidence -30885716 − 1824285 U001 Exact free cash flow: -32710001 U001 2021-01-01 – 2021-12-31: -30885716 U001 · Inspect Operating Cash Flow · Source 2021-01-01 – 2021-12-31: 1824285 U001 · Inspect Capital Expenditure · Source Share or cite Citation for Free cash flow · Chembio Diagnostics, Inc. · 2021-12-31 Chembio Diagnostics, Inc. (edgar:1092662) Free cash flow: -32710001 U001 Concept: free-cash-flow Period: 2021-01-01 to 2021-12-31 Values: Latest reported Published: 2026-11-02T09:19:19Z Snapshot: 3e30444a4216581077c44f423ce8be06ef2be4055b160acf7d3e4d2760732832 Dimensions: Consolidated View: https://fundies.io/companies/edgar/1092662?view=overview&cadence=annual&surface=latest#cash-generation-title Computed: Operating cash flow minus capital expenditure Input fundies:OperatingCashFlow: -30885716 U001 (2021-01-01 to 2021-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1092662/000114036123014526/brhc10050381_10k.htm#1696375 Filing: 000114036123014526 Input fundies:CapitalExpenditure: 1824285 U001 (2021-01-01 to 2021-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1092662/000114036122007735/brhc10034606_10k.htm#1271194 Filing: 000114036122007735 The citation records this snapshot. The page link may show a newer release later.
2022 2022-01-01 – 2022-12-31	−U001 23.29 million Exact value Exact value: -23290657 U001 2022-01-01 – 2022-12-31: -23290657 U001 Inspect Net Income Open source Share or cite Citation for Net Income · Chembio Diagnostics, Inc. · 2022-12-31 Chembio Diagnostics, Inc. (edgar:1092662) Net Income: -23290657 U001 Concept: fundies:NetIncome Period: 2022-01-01 to 2022-12-31 Values: Latest reported Published: 2026-11-02T09:19:19Z Snapshot: 3e30444a4216581077c44f423ce8be06ef2be4055b160acf7d3e4d2760732832 Dimensions: Consolidated View: https://fundies.io/companies/edgar/1092662/explain?concept=fundies%3ANetIncome&period=2022-12-31&surface=latest&period_type=duration&start=2022-01-01&unit=U001&dimensions= Input fundies:NetIncome: -23290657 U001 (2022-01-01 to 2022-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1092662/000114036123014526/brhc10050381_10k.htm#1660723 Filing: 000114036123014526 The citation records this snapshot. The page link may show a newer release later.	−U001 12.69 million Exact value Exact value: -12693953 U001 2022-01-01 – 2022-12-31: -12693953 U001 Inspect Operating Cash Flow Open source Share or cite Citation for Operating Cash Flow · Chembio Diagnostics, Inc. · 2022-12-31 Chembio Diagnostics, Inc. (edgar:1092662) Operating Cash Flow: -12693953 U001 Concept: fundies:OperatingCashFlow Period: 2022-01-01 to 2022-12-31 Values: Latest reported Published: 2026-11-02T09:19:19Z Snapshot: 3e30444a4216581077c44f423ce8be06ef2be4055b160acf7d3e4d2760732832 Dimensions: Consolidated View: https://fundies.io/companies/edgar/1092662/explain?concept=fundies%3AOperatingCashFlow&period=2022-12-31&surface=latest&period_type=duration&start=2022-01-01&unit=U001&dimensions= Input fundies:OperatingCashFlow: -12693953 U001 (2022-01-01 to 2022-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1092662/000114036123014526/brhc10050381_10k.htm#1695257 Filing: 000114036123014526 The citation records this snapshot. The page link may show a newer release later.	Unavailable Not reported for this period.	Unavailable Free cash flow cannot be calculated because Capital expenditure is unavailable for this period.

Capital expenditure uses the canonical mapped positive-spending convention. A missing, ambiguous, incompatible, or negative-sign input is left blank. Values use the latest reported version.

Dataset coverage and company identifiers

Coverage reflects filings processed into this Fundies dataset; it does not imply every source filing is loaded.

142 filings · 4,602 latest values · 4,602 originally reported values

Dataset published 2026-11-02. Source filing dates and reporting periods are shown separately.

Identifiers: 0001092662, 1092662, CEMI, edgar:1092662

Also known as CHEMBIO DIAGNOSTICS, INC., Chembio Diagnostics Inc., Chembio Diagnostics, Inc., TRADING SOLUTIONS COM INC

Chembio Diagnostics, Inc.

Latest quarter

Revenue

Operating margin

Operating cash flow

Reported share-count change

Company performance

What changed year over year

Revenue

Net income

Operating cash flow

Where revenue goes

2022 2022-01-01 – 2022-12-31

Cash

Share of revenue by period

Growth

Profit and cash

Balance sheet

Cash generation